Ozempic vs MetforminOzempic vs metformin — a GLP-1 vs the first-line biguanide. Different mechanisms, complementary roles, often used together in diabetes.

Short answer: Ozempic and metformin aren't competitors — they're complementary. Metformin is first-line, cheap, oral, modest weight-neutral; Ozempic is a weekly injection with stronger glucose and weight effects plus CV/renal benefit. Most diabetics on Ozempic stay on metformin too.

Different jobs

	Metformin	Ozempic
Class	Biguanide	GLP-1 agonist
Form	Daily oral	Weekly injection
Mechanism	Reduces liver glucose output	Incretin — insulin+glucagon+appetite
Weight effect	Neutral/modest loss	~15% at obesity doses
CV/renal benefit	Modest	Demonstrated (SUSTAIN-6, FLOW)
Cost	Very cheap	Premium
Role	First-line foundation	Add-on or escalation

Used together

Combination therapy is standard — metformin provides baseline insulin-sensitizing; Ozempic adds incretin effect. Adding Ozempic doesn't mean stopping metformin.

Ozempic (semaglutide) FDA Prescribing Information, Novo Nordisk, 2024.

STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding et al., NEJM 2021).

SUSTAIN 6 — Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (Marso et al., NEJM 2016).

American Diabetes Association — Standards of Care in Diabetes — 2026.

NICE Guideline NG28 — Type 2 diabetes in adults: management.

World Health Organization — Diabetes fact sheet.

Browse all pages